Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Cancer Research and Treatment|July 10, 2025
Barriers to Clinical Trial Enrollment: KCSG Survey-Based Perspectives of Medical Oncologists, Patients, and Their CaregiversChi Hoon Maeng, Inkeun Park, In Hee Lee, et al.
Plos One|June 13, 2023
Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expressionMin Hee Kim, Eun-Ji Lee, Su-Jeong Kim, et al.
Thoracic Cancer|February 9, 2019
Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancerEun Young Kim, Inkeun Park, Young Saing Kim, et al.
Clinics in Orthopedic Surgery|June 10, 2022
An Increasing Trend in the Number of Anterior Cruciate Ligament Reconstruction in Korea: A Nationwide Epidemiologic StudyKyu Sung Chung, Jung Hoon Kim, Doo Hwan Kong, et al.
Clinical Genitourinary Cancer|January 16, 2024
Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paragangliomaYoung-Gyu Park, Inkeun Park, Yongjae Kim, et al.
Journal of Translational Medicine|December 30, 2018
FGFR1 expression defines clinically distinct subtypes in pancreatic cancerFarhan Haq, You-Na Sung, Inkeun Park, et al.
Frontiers in Immunology|May 6, 2022
AHCC®, a Standardized Extract of Cultured Lentinula Edodes Mycelia, Promotes the Anti-Tumor Effect of Dual Immune Checkpoint Blockade Effect in Murine Colon CancerHong-Jai Park, Sunjin Boo, Inkeun Park, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2016
Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CTEun Young Kim, Young Saing Kim, Inkeun Park, et al.
Anticancer Research|February 27, 2026
Erlotinib Induces Cell Death by Blocking NIX-mediated Mitophagy Through Lysosomal Swelling in IDH1-mutant CholangiocarcinomaYonghyun Kang, Chorong Kim, Chan Yeop Jeong, et al.
Cancer Research and Treatment|March 7, 2021
Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5Hyung-Don Kim, Hyeon-Su Im, Jwa Hoon Kim, et al.
Pageof 11